Logotype for Bailador Technology Investments Limited

Bailador Technology Investments (BTI) AGM 2026 presentation summary

Event summary combining transcript, slides, and related documents.

Logotype for Bailador Technology Investments Limited

AGM 2026 presentation summary

13 Oct, 2026

Investment approach and deployment

  • Focus on established, fast-growing IT businesses scaling internationally, targeting the expansion stage for a balance of risk and reward.

  • FY26 follow-on investments totalled $7.6m: $5.0m in DASH, $2.5m in Rosterfy and $0.1m in PropHero.

  • Active support extends beyond capital, with a concentrated portfolio strategy aimed at operational growth and realizing investment gains.

Portfolio performance

  • Underlying portfolio revenue was $735m; weighted revenue growth was 32%, gross margin 63% and recurring revenue 82% in FY26.

  • Portfolio gains were $17.9m, with a 7.5% gross portfolio return; the increase in private portfolio values drove most of the gain.

  • FY26 private valuation changes included Updoc +21%, PropHero +69%, Hapana +17% and MOSH +50%; DASH declined $9.0m, or 20%.

  • SiteMinder's operating performance remained strong; its improvement program reported a 10%+ new-customer win-rate improvement, 10%+ lower cost per support case and over 2x code-change throughput.

Realisations and shareholder returns

  • FY26 cash realisations were $28m, including a $25m SiteMinder partial realisation at 36.9% IRR and 29.4x investment cost.

  • Since inception, cash realisations delivered a 3.5x average MOIC and 23.2% average IRR.

  • FY26 dividends totalled 7.4c per share; the 3.5c final dividend carried a 9.5% grossed-up annualised yield.

  • Annual dividend target is 4% of pre-tax NTA, paid half-yearly and fully franked; a dividend reinvestment plan is in operation.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more

Latest events from Bailador Technology Investments